Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 3 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Lancet. 2019 Nov 23;394(10212):1915-1928. doi: 10.1016/S0140-6736(19)32591-7. Epub 2019 Nov 1.
Lancet. 2019.
PMID: 31679945
Clinical Trial.
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
Hadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ; LIBRETTO-531 Trial Investigators.
Hadoux J, et al.
N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21.
N Engl J Med. 2023.
PMID: 37870969
Clinical Trial.
Item in Clipboard
Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial.
Lim SM, Peters S, Ortega Granados AL, Pinto GDJ, Fuentes CS, Lo Russo G, Schenker M, Ahn JS, Reck M, Szijgyarto Z, Huseinovic N, Zografos E, Buss E, Stjepanovic N, O'Donnell S, de Marinis F.
Lim SM, et al. Among authors: pinto gdj.
Nat Commun. 2023 Nov 11;14(1):7301. doi: 10.1038/s41467-023-42900-4.
Nat Commun. 2023.
PMID: 37951954
Free PMC article.
Clinical Trial.
Item in Clipboard
Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma.
Jacinto AA, Batalha Filho ES, Viana LS, De Marchi P, Capuzzo RC, Gama RR, Boldrini Junior D, Santos CR, Pinto GDJ, Dias JM, Canton HP, Carvalho R, Radicchi LA, Bentzen S, Zubizarreta E, Carvalho AL.
Jacinto AA, et al. Among authors: pinto gdj.
BMC Cancer. 2018 Oct 23;18(1):1026. doi: 10.1186/s12885-018-4893-5.
BMC Cancer. 2018.
PMID: 30352576
Free PMC article.
Clinical Trial.
Item in Clipboard
Mutational profile of Brazilian lung adenocarcinoma unveils association of EGFR mutations with high Asian ancestry and independent prognostic role of KRAS mutations.
Leal LF, de Paula FE, De Marchi P, de Souza Viana L, Pinto GDJ, Carlos CD, Berardinelli GN, Miziara JE, da Silva CM, Silva ECA, Pereira R, de Oliveira MA, Scapulatempo-Neto C, Reis RM.
Leal LF, et al. Among authors: pinto gdj.
Sci Rep. 2019 Mar 1;9(1):3209. doi: 10.1038/s41598-019-39965-x.
Sci Rep. 2019.
PMID: 30824880
Free PMC article.
Item in Clipboard
Impact of AferBio® on quality of life and chemotherapy toxicity in advanced lung cancer patients (AFERBIO study): protocol study for a phase II randomized controlled trial.
D'Almeida Preto D, Baston MT, Geraige CC, Augusto SB, de Oliveira MA, Mamere AE, Pinto GDJ, Dias JM, De Marchi PRM, Paiva BSR, Paiva CE.
D'Almeida Preto D, et al. Among authors: pinto gdj.
BMC Cancer. 2019 Apr 25;19(1):382. doi: 10.1186/s12885-019-5599-z.
BMC Cancer. 2019.
PMID: 31023257
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite